Abstract

Tumour cells employ a variety of mechanisms to invade their environment and to form metastases. An important property is the ability of tumour cells to transition between individual cell invasive mode and collective mode. The switch from collective to individual cell invasion in the breast was shown recently to determine site of subsequent metastasis. Previous studies have suggested a range of invasion modes from single cells to large clusters. Here, we use a novel image analysis method to quantify and categorise invasion. We have developed a process using automated imaging for data collection, unsupervised morphological examination of breast cancer invasion using cognition network technology (CNT) to determine how many patterns of invasion can be reliably discriminated. We used Bayesian network analysis to probabilistically connect morphological variables and therefore determine that two categories of invasion are clearly distinct from one another. The Bayesian network separated individual and collective invading cell groups based on the morphological measurements, with the level of cell-cell contact the most discriminating morphological feature. Smaller invading groups were typified by smoother cellular surfaces than those invading collectively in larger groups. Interestingly, elongation was evident in all invading cell groups and was not a specific feature of single cell invasion as a surrogate of epithelial-mesenchymal transition. In conclusion, the combination of cognition network technology and Bayesian network analysis provides an insight into morphological variables associated with transition of cancer cells between invasion modes. We show that only two morphologically distinct modes of invasion exist.

Highlights

  • Spread and metastasis of breast cancer is responsible for the vast majority of patient morbidity and mortality associated with this disease [1]

  • Invading C35 at high levels (C35hi) cells are comparable to EMTenriched claudin-low breast cancers [35]

  • These observations led to a proposal of four types of invasion: single cells, small groups of cells, cohorts and collective invasion [2]

Read more

Summary

Introduction

Spread and metastasis of breast cancer is responsible for the vast majority of patient morbidity and mortality associated with this disease [1]. The invasive properties of cancer cells underlying metastatic dis-. Ease have been investigated extensively for many years [2,3,4], with new treatments beginning to enter clinical trials. There are few effective, short term biomarkers. Novel approaches in clinical trials include cytotoxins such as taxanes and biological agents, especially those targeting tyrosine kinases such as Trastuzumab (Herceptin) [5]. Anti-angiogenic approaches such as the use of the anti-VEGF-A antibody Bevacizumab (Avastin) in metastatic breast cancer have failed so far to improve the prognosis of metastatic breast cancer patients [6]. The 5-year survival of patients with metastatic

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.